🟢 Danaher is trading 4.3% up today amid a healthcare-sector rally

Danaher is trading 4.3% up at $220.49, with the move appearing primarily sector-driven after Moderna’s late-stage cancer-therapy news.

• Danaher extended its August 19 advance of 5.97%; no fresh company-specific announcement was identified for August 20, 2026.
• The S&P 500 healthcare sector gained 3.5% on August 19, while Danaher is outperforming broader indexes, which are lower during Thursday’s session.
• Recent earnings and CEO-transition coverage is older and does not directly explain today’s move.